Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.360
-0.010 (-0.30%)
Mar 20, 2026, 11:11 AM EDT - Market open
Recursion Pharmaceuticals Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$7.50
Upside
+123.21%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +78.57% | Feb 26, 2026 |
| Needham | Needham | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +138.10% | Feb 26, 2026 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades $10 → $11 | Hold → Buy | Upgrades | $10 → $11 | +227.38% | Dec 17, 2025 |
| Needham | Needham | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +138.10% | Sep 11, 2025 |
| Needham | Needham | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +138.10% | Jul 8, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $5 | Hold | Initiates | $5 | +48.81% | Jul 3, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $8 → $5 | Hold | Maintains | $8 → $5 | +48.81% | Jun 16, 2025 |
| Needham | Needham | Strong Buy Maintains $11 → $8 | Strong Buy | Maintains | $11 → $8 | +138.10% | May 6, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $10 → $8 | Hold | Maintains | $10 → $8 | +138.10% | Apr 10, 2025 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +227.38% | Apr 8, 2025 |
| Leerink Partners | Leerink Partners | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +78.57% | Feb 28, 2025 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +227.38% | Feb 6, 2025 |
| Keybanc | Keybanc | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +197.62% | Jan 8, 2025 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +227.38% | Dec 11, 2024 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +227.38% | Nov 20, 2024 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +227.38% | Nov 7, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.